Markets › Super Investors › Ipca Laboratories Limited
IL
Ipca Laboratories Limited
Corporate / BodyDisclosed Indian equity holdings above the 1% filing threshold.
Disclosed value
₹1,808 Cr
Today
−₹23.9 Cr -1.30%
Companies
3
As of
31 Mar 2026
Returns vs NIFTY current basket, 1 year
This portfolio -27.1% NIFTY 50 -4.4%behind NIFTY by 22.7 pts
Today’s disclosed holdings valued back over the past year vs the NIFTY 50, rebased to 0%. Not a record of actual trades.
Sector allocation
Portfolio X-ray
Top-5 weight
100%
Wtd P/E
12.3
Wtd ROE
9.8%
Holdings
3
By market cap
Large 0% Mid 0% Small 100%
Holdings · 3
| Company▾ | Stake▾ | Value▼ | Today▾ | Q/Q▾ | P/E▾ | ROE▾ |
|---|---|---|---|---|---|---|
| Unichem Laboratories Ltd UNICHEMLAB · Healthcare | 52.67% | ₹1,631.4 Cr | -1.71% | – | 12.3 | 10% |
| Lyka Labs Ltd LYKALABS · Healthcare | 40.98% | ₹105 Cr | +3.19% | – | – | -11% |
| Krebs Biochemicals and Industries Limited KREBSBIO · Healthcare | 49.65% | ₹71.1 Cr | +1.79% | – | – | – |
Stake history by quarter (%) increased trimmed
| Company | Mar '26 | Dec '25 | Sept '25 | Jun '25 |
|---|---|---|---|---|
| Unichem Laboratories Ltd | 52.67 | 52.67 | 52.67 | 52.67 |
| Lyka Labs Ltd | 40.98 | 40.98 | 40.98 | 40.98 |
| Krebs Biochemicals and Industries Limited | 49.65 | 49.65 | 49.65 | 49.65 |
Holdings are taken exactly as filed in public shareholding disclosures, shown only once a stake crosses the 1% disclosure threshold, so this is the holder’s large positions, not every holding. Value = disclosed shares × latest market price, so it moves daily while share counts update each quarter; “Q/Q” compares with the prior filing (pp = percentage points). Names are shown as filed and folded only for capitalisation and spacing, never different spellings; a common name could, in principle, represent more than one person. For information only, not investment advice.